NAD+ Suppresses EV-D68 Infection by Enhancing Anti-Viral Effect of SIRT1
Viruses · 2025
DOI: 10.3390/v17020175 ↗Kurz gefasst
Fachartikel in der Zeitschrift Viruses, 2025. Verfasst von Yue Wang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Pathogen Biology and Immunology Laboratory, Lab Teaching & Management Center, School of Basic Medical Sciences, Chongqing Medical University, Chongqi…. Hauptthemen laut MEDLINE: Sirtuin 1, NAD, Enterovirus Infections, Enterovirus D, Human. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Chongqing Science and Technology Commission, Yuzhong District Science and Technology Commission.
Abstract (Originalsprache)
Enterovirus 68 (EV-D68) is a non-enveloped virus with a positive-sense single-stranded RNA genome that causes respiratory diseases and acute flaccid myelitis, posing significant threats to human health. However, an effective vaccine remains undeveloped. SIRT1, a nicotinamide adenine dinucleotide (NAD+)-dependent enzyme, plays a key role in cellular metabolism, but its interaction with NAD+ during viral infections is not well understood. In this study, through a metabolomics analysis, we demonstrate that EV-D68 infection influences cellular metabolism. Additionally, we show that NAD+ inhibits EV-D68 infection both in vivo and in vitro. EV-D68 reduces cellular NAD+ levels by regulating the expression of enzymes involved in NAD+ consumption and synthesis. Moreover, the infection increases the expression of sirtuin 1 (SIRT1), which inhibits EV-D68 replication in turn. Mechanistically, SIRT1 suppresses EV-D68 5′UTR-mediated translation, and the antiviral effect of SIRT1 on EV-D68 replication is enhanced by NAD+. Collectively, our findings highlight the critical role of NAD+ metabolism in EV-D68 infection and reveal the antiviral potential of SIRT1, providing valuable insights for the development of antiviral strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Pathogen Biology and Immunology Laboratory, Lab Teaching & Management Center, School of Basic Medical Sciences, Chongqing Medical University, Chongqing 400016, China.
- Institute of Intelligent Traditional Chinese Medicine, Chongqing University of Chinese Medicine, Chongqing 402760, China.
- Second Affiliated Hospital, Army Medical University, Chongqing 400037, China.
ORCID-Profile: Nan Lu
Förderung
- National Natural Science Foundation of China
- Chongqing Science and Technology Commission
- Yuzhong District Science and Technology Commission
- Chongqing Municipal Education Commission
- the Project of Undergraduates Innovating Experiment and the Project of Tutorial System of Excellent Medical Undergraduates
- Chongqing Science and Technology Bureau
- Program for Youth Innovation in Future Medicine, Chongqing Medical University
Zitieren
APA
Wang, Y., Li, H., Huang, X., Huang, Y., Lv, M., Tang, H., Han, X., Liu, J., Liang, Y., Zang, G., Lu, N., & Zhang, G. (2025). NAD+ Suppresses EV-D68 Infection by Enhancing Anti-Viral Effect of SIRT1. Viruses. https://doi.org/10.3390/v17020175
Vancouver
Wang Y, Li H, Huang X, Huang Y, Lv M, Tang H, et al. NAD+ Suppresses EV-D68 Infection by Enhancing Anti-Viral Effect of SIRT1. Viruses. 2025. doi:10.3390/v17020175
BibTeX
@article{Wang2025,
author = {Wang, Yue and Li, Haiyu and Huang, Xia and Huang, Yan and Lv, Mingqi and Tang, Hong and Han, Xinyue and Liu, Juntong and Liang, Yan and Zang, Guangchao and Lu, Nan and Zhang, Guangyuan},
title = {NAD+ Suppresses EV-D68 Infection by Enhancing Anti-Viral Effect of SIRT1},
journal = {Viruses},
year = {2025},
doi = {10.3390/v17020175}
}
EUVIMED